Back
Chemomab Therapeutics Stock Price Chart
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!
Sell
41
CMMB
Chemomab Therapeutics
Last Price:
0.66
Seasonality Move:
-16.27%
7 Day Trial
ALL ACCESS PASS
$
7
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to See- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CMMB is experiencing slight buying pressure.
Chemomab Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.67 | Buy |
| 20-day SMA: | 0.73 | Sell |
| 50-day SMA: | 0.73 | Sell |
| 200-day SMA: | 0.8 | Sell |
| 8-day EMA: | 0.68 | Sell |
| 20-day EMA: | 0.71 | Sell |
| 50-day EMA: | 0.71 | Sell |
| 200-day EMA: | 0.93 | Sell |
Chemomab Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 43.07 | Sell |
| Chaikin Money Flow: | 1124 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Chemomab Therapeutics Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Chemomab Therapeutics Stock
Is Chemomab Therapeutics Stock a Buy?
- Chemomab Therapeutics share price is 0.67 while CMMB 8-day simple moving average is 0.67, which is a Buy signal.
- The stock price of CMMB is 0.67 while Chemomab Therapeutics 20-day SMA is 0.73, which makes it a Sell.
- Chemomab Therapeutics 50-day simple moving average is 0.73 while CMMB share price is 0.67, making it a Sell technically.
- CMMB stock price is 0.67 and Chemomab Therapeutics 200-day simple moving average is 0.80, creating a Sell signal.
CMMB Technical Analysis vs Fundamental Analysis
Sell
41
Chemomab Therapeutics (CMMB)
is a Sell
Is Chemomab Therapeutics a Buy or a Sell?
-
Chemomab Therapeutics stock is rated a Sell
The current Chemomab Therapeutics [CMMB] share price is $0.67. The Score for CMMB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Chemomab Therapeutics Stock Info
Market Cap:
9.52M
Price in USD:
0.67
Share Volume:
3.37K
Chemomab Therapeutics 52-Week Range
52-Week High:
1.89
52-Week Low:
0.42
Sell
41
Chemomab Therapeutics (CMMB)
is a Sell
Chemomab Therapeutics Share Price Forecast
-
What is the Chemomab Therapeutics stock price today?
The Chemomab Therapeutics stock price is 0.67 USD today. -
Will CMMB stock go up or go down?
Chemomab Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Chemomab Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Chemomab Therapeutics is overvalued.
Is Chemomab Therapeutics Stock a Buy?
- Chemomab Therapeutics share price is 0.67 while CMMB 8-day exponential moving average is 0.68, which is a Sell signal.
- The stock price of CMMB is 0.67 while Chemomab Therapeutics 20-day EMA is 0.71, which makes it a Sell.
- Chemomab Therapeutics 50-day exponential moving average is 0.71 while CMMB share price is 0.67, making it a Sell technically.
- CMMB stock price is 0.67 and Chemomab Therapeutics 200-day simple moving average is 0.93, creating a Sell signal.
Fundamental Analysis of Chemomab Therapeutics
Is Chemomab Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.02 per share.
Technical Analysis of Chemomab Therapeutics
Should I short Chemomab Therapeutics stock?
- CMMB Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Chemomab Therapeutics is a Sell
- Chemomab Therapeutics Relative Strength Index (RSI) is 43.07, which suggest Chemomab Therapeutics is oversold
- The Bollinger Bands (25) for Chemomab Therapeutics is ( - ), which suggest Chemomab Therapeutics is a Buy
- The Bollinger Bands (100) for Chemomab Therapeutics is ( - ), which suggest Chemomab Therapeutics is a Buy
* Chemomab Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.